SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001144204-18-039148
Filing Date
2018-07-20
Accepted
2018-07-20 16:18:06
Documents
1
Effectiveness Date
2018-07-20

Document Format Files

Seq Description Document Type Size
1 DEFA14A tv498928_defa14a.htm DEFA14A 21247
  Complete submission text file 0001144204-18-039148.txt   22347
Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36150 | Film No.: 18962657
SIC: 8731 Services-Commercial Physical & Biological Research